Therefore, the tumor expression of the progesterone receptor and estrogen receptor are prognostic biomarkers in certain ovarian cancer subtypes [175] but could also have some predictive value as biomarkers predicting the response to endocrine therapies [176]. This evidence concerns the gene ESR1 and ovarian carcinoma.